Skip to content

Novavax NVAX Finance Lease Liability, Current

Finance Lease Liability, Current at other companies

Moderna logo
ModernaMRNA
$25M+8.7%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$52K
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$1.24M-31.2%

Other financials

Income statement

See full
Revenue$139.5M-79.1%
Gross profit$108.8M-83.3%
Operating income-$15.4M-103%
Net income-$9.5M-102%
EPS (diluted)-$0.06-102%

Balance sheet

See full
Cash & equivalents$228.4M-13.3%
Total debt$295.1M+404%
Total equity-$144.8M-91.4%
Total assets$1.0B-19.3%

Cash flow

See full
Operating cash flow-$32.4M+82.5%
CapEx$1.3M-20.4%
Free cash flow-$33.7M+82.0%

Valuation

See full
Market cap$1.46B+41.0%
Enterprise value$1.53B+83.6%
P/S2.5×+1.6×

Profitability

See full
Gross margin85%-2.5pp
Operating margin-13.1%-45.9pp
Net margin-14.7%-52.9pp
FCF margin-58.9%-61.4pp

Returns & leverage

See full
Return on equity-238.6%
Debt / equity1.5×
Current ratio2.5×+0.4×

Where this comes from

Reported directly by Novavax in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.

The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novavax's finance lease liability, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Novavax's finance lease liability, current?
Novavax (NVAX) reported finance lease liability, current of $2.11M in Q1 2026.
How has Novavax's finance lease liability, current changed year-over-year?
Novavax's finance lease liability, current decreased by 61.4% year-over-year, from $5.48M to $2.11M.
What is the long-term trend for Novavax's finance lease liability, current?
Over 5 years (2020 to 2025), Novavax's finance lease liability, current has grown at a -52.7% compound annual growth rate (CAGR), from $105.86M to $2.51M.
What does finance lease liability, current mean?
Finance lease liabilities (current) represent the portion of lease obligations that are due to be paid within the next twelve months. These obligations arise from long-term contracts where the company effectively controls the leased asset. This metric is critical for assessing near-term liquidity and cash flow requirements.